| Product Name | MF | CAS | Details |
|---|
| 4trans-Hydroxy Cilostazol | C20H27N5O3 | 87153-04-6 | Details |
| Cilostazol Impurity 7 | C20H27N5O3 | 87153-06-8 | Details |
| Saxagliptin Impurity 6 | C10H16N2O3 | 709031-38-9 | Details |
| Saxagliptin Impurity 29 | C11H18N2O3 | 1564266-79-0 | Details |
| Saxagliptin Impurity 9 | C18H24N2O3 | 1350800-77-9 | Details |
| Saxagliptin Impurity 23 | C17H27NO6 | 681282-72-4 | Details |
| Saxagliptin (R,S,R,R)-Isomer | C18H25N3O2 | 1564265-98-0 | Details |
| Saxagliptin Cyclic Amidine Impurity | C18H25N3O2 | 1350800-76-8 | Details |
| Linagliptin Impurity F | C27H27F3N8O3 | 1673546-62-7 | Details |
| Trelagliptin Impurity 18 | C50H56N16O4 | 1418133-47-7 | Details |
| Trelagliptin Impurity 14 | C25H28N8O2 | 1446263-38-2 | Details |
| Linagliptin Impurity B | C30H36N8O4 | 668273-75-4 | Details |
| Linagliptin Impurity J | C20H18N6O2 | 1911621-52-7 | Details |
| Trelagliptin Impurity 25 | C27H30N8O3 | 1803079-49-3 | Details |
| 4-HYDROXYBENZOIC-2,3,5,6-D4 ACID | C7H2D4O3 | 152404-47-2 | Details |
| Aspirin Impurity 8 | C11H10O5 | 18698-59-4 | Details |
| Acetylsalicylic Acid Acyl-β-D-glucuronide | C15H16O10 | 24719-72-0 | Details |
| (5R)-ethyl 5-((1R,3aS,7aR)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldiMethylsilyloxy)-2-Methylenecyclohexylidene)ethyl)-7a-Methyloctahydro-1H-inden-1-yl)hexanoate | C39H70O4Si2 | 169900-32-7 | Details |
| Warfarin Impurity 18 | C19H16O5 | 17834-03-6 | Details |
| Calcitriol Impurity 4 | C28H46O3 | 103656-40-2 | Details |
| Aspirin Impurity G | C14H10O5 | 2513-33-9 | Details |
| Warfarin sodium EP Impurity A | C18H16O2 | 15156-56-6 | Details |
| 8-Hydroxy Warfarin | C19H16O5 | 17834-04-7 | Details |
| (R)-7-Hydroxy Warfarin | C19H16O5 | 63740-76-1 | Details |
| 6-Hydroxy Warfarin | C19H16O5 | 17834-02-5 | Details |
| Warfarin-d5 | C19H16O4 | 75472-93-4 | Details |
| Gentisuric Acid | C9H9NO5 | 25351-24-0 | Details |
| N-glucopyranosyl-5-aminosalicylic acid | C13H17NO8 | 123135-21-7 | Details |
| (1R,3aR,7aR)-1-[(1R)-1,5-Dimethyl-5-[(triethylsilyl)oxy]hexyl]octahydro-7a-methyl-4H-inden-4-one | C24H46O2Si | 144848-24-8 | Details |
| Eldecalcitol Intermediate A | C42H71O5PSi3 | 200636-54-0 | Details |
| 1-(2-Hydroxy-1-Methyl-ethyl)-7a-Methyl-octahydro-inden-4-ol | C13H24O2 | 64190-52-9 | Details |
| Sarpogrelate Metabolite M1 HCl | C20H28ClNO3 | 135261-74-4 | Details |
| Clopidogrel-d4 Carboxylic Acid | C15H10ClD4NO2S | 1246814-52-7 | Details |
| RAC CLOPIDOGREL-D4 HYDROGEN SULFATE | C16H18ClNO6S2 | 1219274-96-0 | Details |
| Clopidogrel EP Impurity E R-Isomer | C15H15ClN2OS | 444728-15-8 | Details |
| Clopidogrel Acyl-beta-D-Glucuronide | C21H22ClNO8S | 1314116-53-4 | Details |
| rac-Clopidogrel-MP Endo Derivative | C25H26ClNO6S | 1346598-12-6 | Details |
| R-Clopidogrel Carboxylic Acid | C15H14ClNO2S | 324757-50-8 | Details |
| Tirofiban hydrochloride monohydrate Impurity B | C13H19NO5S | 149490-60-8 | Details |
| Sarpogrelate iMpurity 2 | C18H20O3 | 1140968-46-2 | Details |
| Sarpogrelate iMpurity 3 | C23H29NO6 | 1659311-47-3 | Details |
| Sarpogrelate iMpurity 4 | C24H31NO7 | 1659311-44-0 | Details |
| Sarpogrelate iMpurity 1 | C16H21NO6 | 1659311-40-6 | Details |
| Tirofiban Impurity 09 | C18H28N2O3 | 158808-75-4 | Details |
| Tirofiban Impurity 23 | C8H11NO2 | 69603-65-2 | Details |
| Tirofiban Impurity 11 | C9H20ClNO | 199475-41-7 | Details |
| Tirofiban Hydrochloride | C22H39ClN2O6S | 142373-60-2 | Details |
| 4-(4-pyridinyl)butyl chloride hydrochloride | C9H13Cl2N | 149463-65-0 | Details |
| Tirofiban Impurity 83 | C10H13NO2 | 85691-54-9 | Details |
| Tirofiban Impurity 49 | C14H21NO5S | 142374-01-4 | Details |
| Clopidogrel Impurity 06 | C17H20ClNO6S2 | 1332612-57-3 | Details |
| Clopidogrel EP Impurity C | C16H18ClNO6S2 | 120202-71-3 | Details |
| trans-Clopidogrel Thiol Metabolite(Mixture of Diastereomers) | C16H18ClNO4S | 767612-34-0 | Details |
| Clopidogrel Related Compound B | C16H16ClNO2S.ClH | 144750-52-7 | Details |
| Beraprost sodium | C24H29NaO5 | 88475-69-8 | Details |
| Acetylsalicylic Acid-d4 | C9H8O4 | 97781-16-3 | Details |
| Clopidogrel EP Impurity B | C16H17Cl2NO2S | 1396607-35-4 | Details |
| Methyl 4-(2-hydroxyphenyl)butanoate | C11H14O3 | 93108-07-7 | Details |
| Dipyridamole Impurity A | C25H40N8O2 | 16982-40-4 | Details |
| Dipyridamole Impurity B | C23H40N8O6 | 16908-47-7 | Details |
| Dipyridamole Impurity F | C21H36N8O5 | 60286-30-8 | Details |
| Dipyridamole EP Impurity D | C22H36N8O3 | 1176886-12-6 | Details |
| Dipyridamole Impurity C | C20H30ClN7O2 | 54093-92-4 | Details |
| Aspirin Impurity 11 | C23H16O8 | 85531-16-4 | Details |
| Aspirin Impurity 3 | C8H7NO5 | 15540-79-1 | Details |
| Saxagliptin Impurity 14 | C11H17NO4 | 197142-36-2 | Details |
| vildagliptin Impurity 59 | C6H10N2 | 20297-37-4 | Details |
| (1R, 3R, 5R, 2'S)-Saxagliptin | C18H25N3O2 | 1564265-94-6 | Details |
| Saxagliptin Impurity 16 | C23H33N3O4 | 709031-43-6 | Details |
| vildagliptin Impurity C | C7H11ClN2O2 | 214398-99-9 | Details |
| vildagliptin Impurity 43 | C7H10N2O2 | 1563006-28-9 | Details |
| vildagliptin Impurity E | C17H25N3O2 | 1789703-37-2 | Details |
| Sitagliptin Impurity 73 | C10H7F3O3 | 1256815-03-8 | Details |
| Sitagliptin Impurity 14 | C16H13F6N5O | 767340-03-4 | Details |
| 2-aMino-2-(3,4,5-trifluorophenyl)acetic acid | C8H6F3NO2 | 261952-27-6 | Details |
| Sitagliptin Impurity 02 | C10H11ClF3NO2 | 1204818-19-8 | Details |
| vildagliptin Impurity F | C17H24N2O3 | 1789703-36-1 | Details |
| Sitagliptin Impurity 72 | C12H11F3O3 | 1151240-88-8 | Details |
| Sitagliptin Impurity2 | C18H17F6N5O2 | 1379666-94-0 | Details |
| Sitagliptin Impurity 60 | C16H13F6N5O2 | 2088771-61-1 | Details |
| Nateglinide D5 | C19H22D5NO3 | 1227666-13-8 | Details |
| Nateglinide EP Impurity B | C19H27NO3 | 105816-05-5 | Details |
| Nateglinide EP Impurity G | C21H31NO3 | 187728-85-4 | Details |
| Nateglinide Methyl Ester | C20H29NO3 | 105746-47-2 | Details |
| Nateglinide Impurity | C28H36N2O4 | 944746-48-9 | Details |
| Repaglinide Impurity E | C27H36N2O4 | 147852-26-4 | Details |
| 3'-Hydroxy Repaglinide (Mixture of DiastereoMers) | C27H36N2O5 | 874908-14-2 | Details |
| Repaglinide Impurity 9 | C29H40N2O4 | 147770-08-9 | Details |
| Nateglinide EP Impurity C | C19H27NO3 | 105816-06-6 | Details |
| (s)-3-Methyl-1-(2-(piperidin-1-yl)phenyl)butan-1-amine | C16H26N2 | 147769-93-5 | Details |
| Repaglinide-ethyl-d5 | C27H38N2O4 | 1217709-85-7 | Details |
| Epalrestat Impurity 5 | C15H13NO3S2 | 124782-63-4 | Details |
| Epalrestat Impurity 8 | C15H13NO4S | 794510-29-5 | Details |
| Epalrestat Impurity 15 | C5H5NO4S | 31061-24-2 | Details |
| Epalrestat Impurity | C13H18O | 109801-00-5 | Details |
| Epalrestat Impurity 16 | C12H9NO3S2 | 1151944-57-8 | Details |
| Epalrestat (E, E)-Isomer | C15H13NO3S2 | 863988-85-6 | Details |
| Epalrestat Impurity 6 | C15H13NO3S2 | 124782-64-5 | Details |
| Calcitriol Impurity B | C27H44O3 | 66791-71-7 | Details |
| Calcitriol Impurity A | C27H44O3 | 73837-24-8 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 | ||||